2017 American Transplant Congress
Hepatic Artery and Biliary Complications in Liver Transplant Recipients with Radioembolization Bridging Treatment for Hepatocellular Carcinoma.
Locoregional treatments are commonly applied in hepatocellular carcinoma (HCC) patients as a bridge to liver transplantation to prevent tumor progression during waiting time. We hypothesized…2017 American Transplant Congress
Favorable Long-Term Prognosis of Hepatitis B Surface Antigen Positive Intrahepatic Cholangiocarcinoma for Both Hepatic Resection and Incidental Liver Transplantation via Inhibiting Cancer-Associated Lymphangiogenesis.
Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China
Background: In recent years, a few publications indicated that hepatitis B virus (HBV) infection is associated with the prognosis of patients with ICC after resection.…2017 American Transplant Congress
Antibiotic Conservatorship in Orthotopic Liver Transplantation.
Post-orthotopic liver transplantation (OLT) infections, especially multidrug resistant organisms (MDRO), are implicated in poorer outcomes, fueling efforts to elucidate risk factors for hospital acquired infections.…2017 American Transplant Congress
Risk Analysis of Patients with Proven Coronary Artery Disease Undergoing Liver Transplant.
Houston Methodist Hospital, Houston, TX
ObjectivesCoronary artery disease is increasing common in liver transplant (LT) candidates due to the aging population. We sought to longitudinally evaluate of outcomes of LT…2017 American Transplant Congress
Outcomes of Combined Liver/Lung Transplantation for Cystic Fibrosis Using SRTR Analysis.
Cystic fibrosis is a genetic multi-system disease affecting approximately 1 in every 2500 newborns globally. Pulmonary transplantation is indicated in patients with severe bronchiectasis and…2017 American Transplant Congress
Pediatric Liver Transplantation for Alpha-1 Antritrypsin Deficiency: A UNOS Database Analysis.
PurposeAlpha-1 Antritypsin Deficiency (ATD) is a heterogeneous disease, and is an important indication for liver transplantation (LT) in children. We examine the ATD population requiring…2017 American Transplant Congress
Status 1 Liver Transplantation: Changes in Characteristics and Outcome Over Time.
General Surgery, University of Hawaii, JABSOM, Honolulu, HI
Purpose: Approximately 5% of liver transplants (LT) annually require this urgently as “Status 1." The aim of this study is to characterize patients who received…2017 American Transplant Congress
Rates of Lost to Follow-Up Among Pediatric Heart, Kidney, and Liver Transplant Recipients.
Background. Pediatric transplant recipients are typically transitioned to adult transplant programs for post-transplant care after age 18. For pediatric kidney (KI) recipients transitioning to adult…2017 American Transplant Congress
Rapamycin Maintenance Therapy in Pediatric Liver Transplant Recipients Associated with Trend Toward Decreasing Th2 Cytokine Levels Compared to Tacrolimus Therapy.
1Children's Mercy Hospital, Kansas City, MO; 2University of Kansas Medical Center, Kansas City, KS
Background: Maintenance immunosuppression after liver transplantation with tacrolimus (TAC) may have progressive fibrosis on serial allograft biopsies. mTOR inhibitors such as rapamycin (RAPA) may abrogate…2017 American Transplant Congress
Disease Progression on Neoadjuvant Chemotherapy Is a Strong Predictor of Recurrence for Pediatric Hepatoblastoma.
1Surgery, Baylor College of Medicine, Houston; 2Surgery, Texas Children's Hospital, Houston
Purpose. In addition to peri-operative chemotherapy, proper triage between orthotopic liver transplantation (OLT) and partial hepatectomy (PH) is critical to limiting disease recurrence in pediatric…
- « Previous Page
- 1
- …
- 121
- 122
- 123
- 124
- 125
- …
- 180
- Next Page »